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Rebecca Palmer, Munyaradzi Dimairo, Cindy Cooper, Pam Enderby, Marian Brady, Audrey Bowen, Nicholas Latimer, Steven Julious, 
Elizabeth Cross, Abualbishr Alshreef, Madeleine Harrison, Ellen Bradley, Helen Witts, Tim Chater
Summary
Background Post-stroke aphasia might improve over many years with speech and language therapy; however speech and 
language therapy is often less readily available beyond a few months after stroke. We assessed self-managed computerised 
speech and language therapy (CSLT) as a means of providing more therapy than patients can access through usual 
care alone.
Methods In this pragmatic, superiority, three-arm, individually randomised, single-blind, parallel group trial, patients 
were recruited from 21 speech and language therapy departments in the UK. Participants were aged 18 years or older 
and had been diagnosed with aphasia post-stroke at least 4 months before randomisation; they were excluded if they 
had another premorbid speech and language disorder caused by a neurological deicit other than stroke, required 
treatment in a language other than English, or if they were currently using computer-based word-inding speech 
therapy. Participants were randomly assigned (1:1:1) to either 6 months of usual care (usual care group), daily self-
managed CSLT plus usual care (CSLT group), or attention control plus usual care (attention control group) with the 
use of computer-generated stratiied blocked randomisation (randomly ordered blocks of sizes three and six, 
stratiied by site and severity of word inding at baseline based on CAT Naming Objects test scores). Only the 
outcome assessors and trial statistician were masked to the treatment allocation. The speech and language therapists 
who were doing the outcome assessments were diferent from those informing participants about which group they 
were assigned to and from those delivering all interventions. The statistician responsible for generating the 
randomisation schedule was separate from those doing the analysis. Co-primary outcomes were the change in ability 
to retrieve personally relevant words in a picture naming test (with 10% mean diference in change considered a 
priori as clinically meaningful) and the change in functional communication ability measured by masked ratings of 
video-recorded conversations, with the use of Therapy Outcome Measures (TOMs), between baseline and 6 months 
after randomisation (with a standardised mean diference in change of 0·45 considered a priori as clinically 
meaningful). Primary analysis was based on the modiied intention-to-treat (mITT) population, which included 
randomly assigned patients who gave informed consent and excluded those without 6-month outcome measures. 
Safety analysis included all participants. This trial has been completed and was registered with the ISRCTN, number 
ISRCTN68798818.
Findings From Oct 20, 2014, to Aug 18, 2016, 818 patients were assessed for eligibility, of which 278 (34%) participants 
were randomly assigned (101 [36%] to the usual care group; 97 [35%] to the CSLT group; 80 [29%] to the attention 
control group). 86 patients in the usual care group, 83 in the CSLT group, and 71 in the attention control group 
contributed to the mITT. Mean word inding improvements were 1·1% (SD 11·2) in the usual care group, 16·4% (15·3) 
in the CSLT group, and 2·4% (8·8) in the attention control group. Word inding improvement was 16·2% (95% CI 
12·7 to 19·6; p<0·0001) higher in the CSLT group than in the usual care group and was 14·4% (10·8 to 18·1) higher 
than in the attention control group. Mean changes in TOMs were 0·05 (SD 0·59) in the usual care group (n=84), 
0·04 (0·58) in the CSLT group (n=81), and 0·10 (0·61) in the attention control group (n=68); the mean diference in 
change between the CSLT and usual care groups was –0·03 (–0·21 to 0·14; p=0·709) and between the CSLT 
and attention control groups was –0·01 (–0·20 to 0·18). The incidence of serious adverse events per year were 
rare with 0·23 events in the usual care group, 0·11 in the CSLT group, and 0·16 in the attention control group. 
40 (89%) of 45 serious adverse events were unrelated to trial activity and the remaining ive (11%) of 45 serious 
adverse events were classiied as unlikely to be related to trial activity.
Interpretation CSLT plus usual care resulted in a clinically signiicant improvement in personally relevant word 
inding but did not result in an improvement in conversation. Future studies should explore ways to generalise new 
vocabulary to conversation for patients with chronic aphasia post-stroke.
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Research in context
Evidence before this study
People with chronic aphasia post-stroke often want and require 
more speech and language therapy than they can access. We 
searched the Cochrane Library and Medline for systematic 
reviews and randomised controlled trials of interventions or 
service delivery for chronic aphasia in post-stroke populations, 
using the search terms “aphasia OR dysphasia AND therapy OR 
treatment AND stroke”. We included papers published in 
English between Jan 1, 2010, and Feb 8, 2019. Studies of drug 
therapies, electrical stimulation, alternative medicine, and 
randomised controlled trials without between-group 
comparisons were excluded. The FCET2EC trial (From Controlled 
Experimental Trial 2 Everyday Communication) was a 
high-quality randomised controlled trial of 158 patients with 
post-stroke aphasia, with a low risk of bias due to computer 
generated randomisation and masked outcome measure 
assessors. This trial showed the effectiveness of speech and 
language therapy (≥10 h per week for 3 weeks) for patients with 
chronic aphasia compared with controls on a waiting list for 
therapy, with benefits still evident at 6 months after treatment, 
and it supports findings from smaller trials (n=20 or fewer per 
group) that chronic post-stroke aphasia can improve with 
speech and language therapy. Due to resource limitations, 
computer therapy has been explored as a potentially efficient 
method of delivering sufficient quantities of speech and 
language therapy. Systematic reviews of computer-based 
speech and language therapy for patients with aphasia suggest 
that it might be more effective than no therapy and just as 
effective as face-to-face therapy. However, the quality of the 
studies included in the systematic reviews was low, with small 
sample sizes (n=55 or fewer). Only two of the studies assessed 
maintenance of treatment effect and only one considered the 
effect on functional communication. One small scale pilot study 
(n=34) included health economic evaluation, which suggested 
potential cost-effectiveness of CSLT.
Added value of this study
The Big CACTUS trial is the first multicentre randomised 
controlled trial in patients with post-stroke chronic aphasia 
(>6 months) to assess both the clinical and cost-effectiveness 
of self-managed word finding therapy with specialist aphasia 
computer software. It is also the first randomised controlled 
trial powered to detect a meaningful difference in clinical 
outcomes. Our trial shows that it is feasible and acceptable to 
provide computerised therapy in routine clinical contexts 
increasing the availability of speech and language therapy 
provision. The findings provide robust evidence that patients 
with chronic aphasia can achieve improvement in their word 
finding, which is maintained after a 6-month follow-up period 
through self-managed practice with a computer. However, the 
improvement did not generalise to conversation. Health 
economic evaluation suggests that this low-cost intervention is 
more likely to be cost-effective for patients with mild and 
moderate word finding difficulties than for all patients with 
chronic aphasia.
Implications of all the evidence
Self-managed computer therapy can be integrated into speech 
and language therapy services to enable availability of effective 
amounts of repetitive practice to improve and maintain retrieval 
of treated words in people with chronic aphasia. However, new 
ways to support generalisation of new vocabulary into everyday 
conversation must be explored. 
Introduction
Aphasia afects the comprehension and expression of 
speech, reading, and writing, which can afect a patient’s 
mood, cause them to feel isolated, and can alter 
their relation ships with family and their role within the 
com munity.1,2 More than one third of stroke survivors 
acquire this disorder,1 of whom 30–43% remain afected 
long-term.1
A Cochrane review2 suggested that patients with chronic 
aphasia (>6 months) could improve their language skills 
with speech and language therapy. A subsequent random-
ised controlled trial3 added to this evidence, showing that 
at least 10 h a week of speech and language therapy for 
3 weeks was efective in improving functional outcomes 
in chronic aphasia, with treatment efects remaining 
stable after 6 months. However, due to the health-care 
costs in providing therapeutic amounts of speech and 
language therapy in the longer term4,5 and that patients 
with aphasia often want more therapy than they are able 
to access,4 an efective and low-cost approach to delivering 
speech and language therapy is required. 
Systematic reviews2,6 of small randomised studies 
(n=18–55) suggest computer therapy might be an efective 
way to provide speech and language therapy to patients 
with chronic aphasia. A pilot study of 34 patients7 sug-
gested that a self-managed, computerised, word ind-
ing therapy approach was feasible, acceptable, and had 
potential clinical efectiveness and cost-efectiveness.7,8
We assessed the clinical and cost-efectiveness of self-
managed computer speech and language therapy (CSLT) 
for word inding in patients with chronic aphasia lasting 
at least 4 months after stroke.9 The key hypothesis was that 
CSLT plus usual care would improve word inding ability 
and as a result would improve functional com munica -
tion in conversation  compared with usual care alone or 
attention control plus usual care.
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Methods
Study design and participants
Big CACTUS was a pragmatic, superiority, three-arm, 
individually randomised, single-blind, parallel group, 
randomised controlled trial. Patients were recruited from 
21 community speech and language therapy departments 
within 20 UK National Health Service (NHS) Trusts 
(appendix p 21). We designed a pragmatic study, using the 
pragmatic-explanatory continuum indicator summary 
(PRECIS) domains (appendix p 105).10
Patients were eligible if they were aged 18 years or older 
and had aphasia conirmed by a speech and language 
therapist after one or more strokes at least 4 months before 
randomisation. Patients had word inding di culties 
(deined by a score of 5–43 out of 48 on the Comprehensive 
Aphasia Test [CAT] Naming Objects test),11 could perform 
a simple matching task on the StepByStep computer 
program12 with at least 50% accuracy (score of 5 out of 10 
or higher), and could repeat at least 50% of words in a 
repetition task on StepByStep (score of 5 out of 10 or 
higher). Patients were excluded if they had a premorbid 
speech and language disorder caused by a neurological 
deicit other than stroke, if they required treatment for 
a language other than English (because the StepByStep 
software used for therapy was in English), or if they 
were cur rently using a word inding computer program, 
including StepByStep.
Eligible patients were identiied by practising speech 
and language therapists from past and current caseloads 
and voluntary sector support groups. Therapists used a 
Consent Support Tool13 to identify the level of support 
required for each patient with aphasia to provide written 
informed consent and to identify those who required a 
carer to provide written consent or a declaration of belief 
that they wished to take part.
Ethics approval was obtained from Leeds West 
NHS research ethics committee [reference 13/YH/0377] 
and Scotland A research ethics committee [reference 
14/SS/0023]. The full protocol is available online. No major 
changes to methods or design were made once the trial 
had started.
Randomisation and masking
We used a centralised web-based randomisation system to 
randomly assign patients to one of three interventions: 
usual care, CSLT plus usual care (CSLT group), or atten-
tion control plus usual care (attention control group), 
using a ixed 1:1:1 allocation ratio. This system used 
stratiied block randomisation with randomly ordered 
blocks of sizes three and six, stratiied by site and severity 
of word inding at baseline based on CAT Naming 
Objects test scores:11 mild (31–43), moderate (18–30), and 
sev ere (5–17). Only the independent randomisation statis-
ti cian knew the block sizes, which were not disclosed until 
after the trial ended. The statistician used the restricted-
access randomisation system to specify the randomisation 
details and to generate the randomisation schedule, which 
was retained within the system. Therapists randomly 
assigned patients using the online system and disclosed 
the allocation to the patient.
We could not mask patients and treating therapists to 
intervention allocation. However, the therapists perfor-
med baseline assessments before randomisation and 
therefore completed these masked to treatment allocation. 
The therapists who performed baseline assessments also 
provided CSLT and attention control interventions. There-
fore, we trained separate therapists (outcome assessors), 
masked to intervention allocation, to do follow-up assess-
ments at each site. Video recordings of conversations 
between patients and therapist assessors at baseline and 
follow-up were rated independently of the therapist team 
who delivered the intervention by speech and language 
therapists who were not involved in the trial, ensuring 
raters were masked to intervention allocation and time-
point of measurement. Further details regarding mask-
ing and assessment of its success are described in the 
appendix (p 11, 98, 100).
Procedures
The interventions of this trial are described in detail 
using the TIDieR template (table 1).14 Patients in all 
three inter vention groups were provided with usual care. 
To establish what constituted as usual care, speech and 
language therapy was recorded for 3 months before 
patients who had chronic aphasia longer than 4 months 
after stroke were randomised.5 Usual speech and language 
therapy continued to be provided to patients in all inter-
vention groups to assess the efectiveness of CSLT in 
addition to usual therapy currently received rather than in 
place of it. 
Patients assigned to the CSLT group completed daily, 
self-managed, word-inding exercises on a computer at 
home, which were tailored to the needs of the individual 
patient by a qualiied speech and language therapist 
experienced in working with patients with stroke in 
routine clinical practice. Each patient chose 100 words 
that were relevant to them, before they were randomly 
assigned to one of the intervention groups, which were 
then used for computerised word inding practice. Prac-
tice was supported by a therapy assistant or volunteer 
under the supervision of the therapist for 6 months. 
Patients in the attention control group were asked to 
complete paper-based puzzle book activities (eg, sudoku, 
spot the diference, word searches, or colouring) on a daily 
basis and received supportive telephone calls from the 
research team once a month. The type and di culty of 
the puzzle book was established by the therapist who did 
the baseline assessments and the research team sent new 
books each month on the basis of the phone call dis-
cussions. If they wished, patients were able to continue 
using CSLT after the 6-month supported period if they still 
had access to it (given that CSLT often required laptops 
that had been lent, and might have subsequently been 
required by a new patient). Participants in the attention 
For study protocol see 
https://www.sheffield.ac.uk/
polopoly_fs/1.801016!/file/
BigCACTUS_Protocol_
v5.0_31may17.pdf
See Online for appendix
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control group were also able to continue completing the 
paper-based puzzle books after 6 months if they wished 
by purchasing them themselves from high-street shops. 
Study visits were scheduled at baseline before randomi-
sation, and then at 6 months, 9 months, and 12 months 
after randomisation. Qualiied therapists from the local 
speech and language therapy team visited patients in their 
own homes to carry out assessments. Therapists aimed 
to complete follow-up visits within 1 month after the 
scheduled timepoint. Clinical assessment comprised a 
CAT comprehension test (baseline visit only);11 a picture 
naming test of 100 personally relevant words (co-primary 
outcome measurement); a 10 min conversation between 
the therapist and patient, structured around topics of 
personal importance to the patient, which was videoed 
and later assessed using the activity scale of the Therapy 
Outcome Measures (TOMs; a co-primary outcome meas-
urement),16 once all of the conversations had been made 
Usual care CSLT Attention control
Why? To improve the communication of people 
with aphasia and to reduce the impact of 
aphasia on their lives.
To provide increased amounts of SLT long-term 
for people with word finding difficulties 
post-stroke. The aim was to adhere to key 
principles of experience-dependent 
neuroplasticity (salience, repetition, feedback).15
To differentiate the SLT components of CSLT 
from additional activity and attention received.
What? Assessment and review of language 
abilities and their impact, rehabilitation of 
different language domains, enabling 
communication using communication aids 
or compensatory strategies, or support for 
mood, confidence, work, family, form 
completion, and information provision.5
Word finding exercises were provided on a 
computer (PC, laptop, or tablet) owned by 
the participant or loaned by the NHS trust. 
The StepByStep aphasia software12 was used as 
it can be tailored to the individual’s needs, 
allows presentation of personally relevant 
words (eg, grandchildren’s names), encourages 
repetitive practice, and provides feedback 
about whether the words used are correct.
Puzzle books (Sudoku, spot the difference, 
mazes, word searches, cross words, colouring).
Who provided? Speech and language therapists or therapy 
assistants.
Speech and language therapists provided the 
software. Volunteers or therapy assistants 
provided encouragement and support to 
practise computer exercises, practised using 
new words in functional contexts, and fed 
back on progress to the therapist.
Speech and language therapists provided the 
first puzzle book and a research assistant from 
the central Big CACTUS team sent out books 
thereafter. Monthly telephone calls were 
made by the research team to provide support 
and identify the type of puzzle book to be sent 
next.
How? Face-to-face on a one-to-one basis or in 
a group.
Practice of the word finding exercises on the 
computer was self-managed by participants.
Puzzle books were completed independently 
by the participants.
Where? Participants’ own homes, or outpatient or 
community clinical facility.
Participants’ own homes. Participants’ own homes.
When and how 
much?
60% of participants were not in receipt of 
SLT in the three months prior to 
randomisation. The remaining 
40% received a median average of 
5 h 20 minutes over 3 months in 1-hour 
sessions every two weeks. This decreased 
with time post-stroke.5
20–30 min practice daily was recommended 
over a 6-month period (based on feasibility 
shown in the pilot study).7 Volunteers or 
therapists assistants were asked to visit for at 
least 1 h once a month.
A recommendation of completing one puzzle 
daily over a 6-month period was made. The 
Aphasia Patient and Public Involvement 
group considered one puzzle could take a 
similar amount of time to complete as the 
daily time spent using the computer exercises. 
Telephone calls were made monthly (need for 
new puzzle books was established during this 
call and requests for new books could be 
made between calls).
Tailoring Tailored to individual needs and 
preferences at the discretion of the 
treating therapist.
Therapists chose therapy exercises based on 
the results of baseline language assessments. 
They also worked with the participants and 
their families to identify 100 words of personal 
relevance for therapy practice.
Therapists matched the first book to the 
participant’s abilities and interests. 
Subsequent books were provided according to 
feedback from the participant or carer.
Modifications No modifications were requested by the 
trial team.
Therapists were advised that they could set the 
100 words up in stages rather than all at once.
No modifications were made.
How well? Fidelity to the provision of usual care for 
all three groups was measured by 
recording the amounts received by each 
group throughout the trial and checking 
they were similar to each other (there was 
an expectation that average amounts of 
usual care would decrease across the trial 
period as the strokes became longer ago 
and SLT commonly decreases over time).5
Therapists were provided with 1-day training 
on the intervention. An intervention manual 
was provided.* Fidelity to practice adherence 
and quality of therapy delivery by the therapists 
and volunteers or therapy assistants was 
assessed (see appendix p 106).
Adherence was measured using number of 
puzzle books sent and number of telephone 
contacts made (minimum of four books and 
four calls expected).
CSLT=computerised speech and language therapy. NHS=National Health Service. PC=personal computer. SLT=speech and language therapy. *For the intervention manual, please 
see online. 
Table 1: TIDieR template of trial interventions
For the intervention manual see 
https://www.sheffield.ac.uk/
polopoly_fs/1.525339!/file/
TherapyManual_Nov15.pdf
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and their presentation could be randomly assigned to 
masked raters. The number of treated words used in 
conversation were also counted (secondary outcome) by 
two members of the central research team (who were 
masked to the timepoint of the video conversation and 
the group allocation of the participant). Further secondary 
outcome measurements included the Communication 
Outcomes After Stroke (COAST)17 questionnaire (the key 
secondary outcome according to our Hochberg statistical 
testing procedure), self-rated by the patient; the CAT 
Naming Objects test;11 and the CarerCOAST18 question-
naire, self-rated by the carer about themselves and the 
patient (appendix p 14).
For the health economic outcome evaluation, an access-
ible (aphasia-friendly) variant of the EuroQoL instrument, 
a ive-dimensional 5-level generic instrument (EQ-5D-5L) 
that measures quality of life (QoL), was developed to 
facilitate patient self-completion.19 When a carer was 
available, the standard EQ-5D-5L20 was also completed on 
behalf of patients. To assess the health-related QoL of 
carers, carers completed the standard EQ-5D-5L and 
CarerQoL questionnaires.
Assessors asked about adverse events and serious 
adverse events 3 months after randomisation by tele phone 
and at all follow-up visits. Assessors asked whether any 
events had occurred (not necessarily side-efects of the 
intervention), using a predeined prompt sheet, but if a 
therapist or member of the research team became aware of 
any events between these assessments, these were also 
recorded. The events were then classiied into adverse 
events and serious adverse events using International 
Conference on Harmonisation Good Clinical Practice 
classiications. Patients of the CSLT group were addi-
tionally sent postal questionnaires each month, between 
randomisation and the 6-month follow-up, to report 
whether they had experienced any negative efects of CSLT.
Outcomes
Co-primary outcomes were the change in ability to 
retrieve vocabulary of personal relevance (impairment), 
measured by a picture naming test of 100 personally 
relevant words (appendix pp 13–15), and the change in 
functional com mun i ca tion ability (activity) measured by 
masked ratings of videoed conversations, with the use of 
the TOMs activity scale, between baseline and 6 months 
after randomisation. 
The key secondary outcome was change in self-
perception of communication, social participation, and 
QoL between baseline and 6 months after randomis a-
tion, measured by COAST. Maintenance of treatment 
efect was assessed by repeating the assessments used to 
measure co-primary and key secondary outcomes at 
9-month and 12-month follow-ups. Additional sec ondary 
outcomes assessed at 6-month, 9-month, and 12-month 
follow-ups were change in the number of treated words 
(ie, words used in treatment, as chosen by the participants 
before randomisation) used in videoed conversations (use 
of speciic words prac tised), generalisation to untreated 
words (ie, words that were not used in therapy) measured 
by the CAT Naming Objects test, change in carer’s percept-
ion of patient’s communication and social participa tion 
(assessed using the irst 15 items of the CarerCOAST), 
and change in carer’s QoL (assessed using the last ive 
items of the CarerCOAST).
Safety outcomes included negative efects of CSLT 
assessed monthly for 6 months after randomisation 
through postal questionnaire and adverse events and 
serious adverse events reported at 3, 6, 9, and 12 months. 
See full protocol for negative efects, adverse events, and 
serious adverse events recorded.
Health-related QoL (HRQoL) was measured at baseline, 
6, 9, and 12 months by the patients who completed the 
accessible EQ-5D-5L, and for those who had a carer, the 
EQ-5D-5L was also completed by their carer on their 
behalf. The EQ-5D-5Ls were used to calculate utility scores 
and quality-adjusted life-years (QALYs), and resource use 
was measured to allow estimation of cost-efectiveness. 
Carer HRQoL was measured using the EQ-5D-5L and the 
CarerQoL.
Statistical analysis
We aimed to recruit 285 participants (95 per group), which 
had 90% power for a 5% two-sided test to address both co-
primary objectives. Based on the consensus by therapists 
on the trial team and the Aphasia Patient and Public 
Involvement group, we considered a 10% mean diference 
in change in word inding (SD 17·38 from analysis of 
covariance model) to be a minimal, clinically important 
diference. We used a TOMs standardised efect size of 
0·45, similar to the ACTNoW study21 of aphasia therapy. 
Sample size was adjusted for a 15% dropout rate observed 
in the pilot trial7 and inlated by 1·1422,23 to account for the 
variance being estimated from a small pilot trial (n=34)7 
and 0·5 correlation between baseline and TOMs outcome. 
This sample size of 285 participants had 83% power for a 
5% two-sided test to address the key secondary objective, 
assumed a 7·2% mean diference (SD 18) as clinically 
worth while, and 0·5 correlation between baseline and 
COAST outcome. See the statistical analysis plan for more 
details. We terminated recruitment after 278 of the 
planned 285 participants had been enrolled, because the 
observed dropout rate (9%) was lower than anticipated 
(15%) and the study had the desired statistical power to 
address the co-primary objectives.
We based the analysis of the primary outcomes 
(6 months after randomisation) on a modiied intention-
to-treat (mITT) principle, which included randomly 
assigned patients who gave informed consent and exclu-
ded those without 6-month outcome measures. We based 
analysis on the treatment patients were randomly assigned 
to. We excluded deaths before assessment at 6 months in 
all clinical efectiveness analyses because the association 
between the interventions and increased risk of mortality 
was viewed as extremely unlikely.
For the full protocol see 
https://www.sheffield.ac.uk/
polopoly_fs/1.801016!/file/
BigCACTUS_Protocol_
v5.0_31may17.pdf
For the statistical analysis plan 
see https://www.sheffield.ac.uk/
polopoly_fs/1.801429!/file/
SAPFinalv1.2.pdf
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We used a multiple linear regression model adjusted for 
baseline outcome measures and ixed stratiication factors 
(site and severity of word inding at baseline). We estimated 
the mean diference in change between the CSLT and 
usual care groups, and CSLT and attention control groups, 
with associated 95% CIs and p values. We analysed all 
clinical outcomes at 9 and 12 months in a similar manner. 
Co-primary, key secondary, and key multiple treatment 
comparisons (CSLT vs usual care and CSLT vs attention 
control) are the sources of multiple hypothesis testing. We 
used a Hochberg hierarchical multiple testing procedure 
to control for the possibility of mak ing false claims about 
clinical beneit at 5% signiicance level on the co-primary 
outcomes and key secondary outcome at 6 months.24 To 
help with the clinical interpretation of superiority of the 
CSLT intervention, we used the Hochberg decision tree 
(appendix p 16). We only report p values where appropriate 
in accordance with the decision tree.
The primary safety analysis included all randomly 
assigned patients with informed consent and according to 
the treatment they received. We summarised the pro-
portion of patients who experienced any negative efects 
of CSLT by classiication. We modelled the number of 
repeated negative efects per classiication using a negative 
binomial regression model accounting for overdispersion 
and follow-up period to estimate the incidence with 
95% CI. We summarised the proportion of patients who 
experienced any adverse event or serious adverse event by 
group and modelled repeated events using a negative 
binomial regression model to estimate the incidence in 
each group, and incidence rate ratio (IRR) between groups 
with associated 95% CI, accounting for overdispersion 
and follow-up period.
We performed per-protocol analysis on the co-primary 
outcomes and key secondary outcome at 6 months for 
patients who adhered to the key components of the 
interventions, including achieving a minimum amount 
of recommended practice and having access to at least 
4 h of support from a volunteer or therapy assistant up 
to the 6-month visit (appendix pp 12, 93). We explored 
potential heterogeneity in intervention efects in pre-
speciied subgroups deined by severity of word inding 
di culty, comprehension ability, and length of time 
post-stroke. We also explored the efect of missing data 
using multiple imputation strategies. See the appendix 
(pp 12–17) for detailed methods, including computa-
tion of summary measures of all clinical outcomes for 
analysis.
The health economic analysis was a model-based cost-
utility analysis adopting a lifetime time horizon and an 
NHS payer perspective. Cost-efectiveness is expressed 
in terms of the incremental cost-efectiveness ratio 
(ICER)—ie, incremental cost per QALY gained. We 
calculated the cost of the interventions by following 
a three-stage process: identiication of resource use, 
meas urement, and valuation using national reference 
unit costs.25 Secondary analyses included analysis of 
subgroups and analyses in which QALY gains were 
based upon EQ-5D-5L responses from carers by proxy. 
The health economic analysis will be fully detailed in a 
future publication. For all the statistical analysis, Stata 
version 15.1 was used.
Figure 1: Trial profile
CSLT=computerised speech language therapy. *Deaths before 6 months excluded in all clinical effectiveness 
analysis but included in safety analysis. †Participants included in the modified intention-to-treat primary 
analysis set.
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 187 ineligible
 41 unwell
 29 did not have enough time
 16 other
 9 refused consent
 8 unable
 8 withdrew consent
 6 no reason given
 5 did not want to use computers
 2 not screened
 1 deceased
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Articles
www.thelancet.com/neurology   Vol 18   September 2019 827
The study was overseen by an independent data man-
agement and ethics committee. The trial was regis tered 
with the ISRCTN registry, number ISRCTN68798818.
Role of the funding source
The National Institute for Health Research (NIHR), 
a funder of the study, commissioned the study and 
requested inclusion of an attention control group. The 
funders of the study had no further role in study design, 
data collection, data analysis, data interpretation, or 
writing of the paper. The corresponding author had full 
access to all the study data and had inal responsibility for 
the decision to submit for publication.
Results
Participants were recruited to the trial between 
Oct 20, 2014, and Aug 18, 2016, and were followed up 
between Oct 24, 2015, and Sept 12, 2017. A total of 
818 participants were screened for eligibility, of whom 
278 (34%) were randomly assigned to the usual care 
group (101 [36%]), the CSLT group (97 [35%]), and the 
attention control group (80 [29%]). Eight participants died 
before 6 months follow-up, 25 withdrew consent, one was 
lost to follow-up, and one was excluded based on investi-
gators’ decisions. Reasons for dropout included personal 
and family issues, unhappiness with allocated study 
group, and unwillingness to complete outcome measures. 
In addition, outcome visits were not done with three 
participants. For further details see appendix (p 18). 
240 (86%) of 278 participants were included as eligible in 
the mITT analysis: 86 (36%) of 240 in the usual care 
group, 83 (35%) of 240 in the CSLT group, 71 (30%) of 
240 in the attention control group (igure 1).
The mean age of all participants was 65·4 years 
(SD 12·9) with a range 23 to 92 years and 164 (61%) of 
270 were men. 119 (44%) of 270 participants had mild 
word inding di culties (CAT Naming Objects test 
score 31–43 points out of 48), 80 (30%) were moderate 
(18–30 points), and 71 (26%) were severe (5–17 points). 
Par tici pants were a median of 2 years (IQR 11 months to 
4 years) post-stroke (range four months to 36 years). 
Intervention groups were broadly similar at baseline 
for both the mITT and multiple imputation analysis 
populations (table 2; appendix p 99). Notable exceptions 
include a greater proportion of participants with severe 
comprehension di culties but a lower proportion of 
participants with severe word inding di cult ies in the 
attention control group than the CSLT or usual care 
groups. The baseline TOMs scores were also slightly 
lower in the attention control group than the other two 
groups.
For the irst co-primary outcome, on average partici-
pants in the CSLT group had improved word inding 
of 16·2% more than those in the usual care group 
(95% CI 12·7–19·6; p<0·0001) and 14·4% more than those 
in the attention control group (10·8–18·1; table 3). The 
efect was in excess of the prespeciied, minimal, clinically 
important diference of 10%. Improvement was main -
tained at 9 and 12 months (igure 2). Per-protocol results, 
which were consistent with the mITT results, are reported 
in the appendix (pp 44–47, 94–97).
Usual care (n=86) CSLT  (n=83) Attention control (n=71)
Sex
Male 54 (63%) 47 (57%) 44 (62%)
Female 32 (37%) 36 (43%) 27 (38%)
Age at consent, years
Mean (SD) 64·9 (13·0) 64·9 (13·0) 63·8 (13·1)
Median (IQR) 66·5 (55·1–74·3) 64·7 (54·5–74·7) 65·1 (53·0–73·4)
Range 23·1–89·6 34·1–89·2 30·4–88·7
CAT comprehension severity*
Within normal limits 17 (20%) 17 (21%) 13 (18%)
Mild 46 (54%) 35 (42%) 31 (44%)
Moderate 20 (23%) 26 (31%) 24 (34%)
Severe 3 (3%) 5 (6%) 3 (4%)
Severity of word finding difficulty†
Mild 35 (41%) 36 (44%) 35 (49%)
Moderate 29 (34%) 26 (31%) 17 (24%)
Severe 22 (25%) 21 (25%) 19 (27%)
Type of aphasia
Anomic 33 (38%) 33 (40%) 19 (27%)
Non-fluent (eg, Broca’s Aphasia) 36 (42%) 34 (41%) 27 (38%)
Mixed non-fluent 13 (15%) 11 (13%) 20 (28%)
Fluent (eg, Wernicke’s Aphasia) 4 (5%) 5 (6%) 5 (7%)
Type of stroke‡
Infarct 69 (80%) 60 (72%) 58 (82%)
Haemorrhage 12 (14%) 13 (16%) 6 (8%)
Not known 9 (10%) 10 (12%) 7 (10%)
Time post-stroke, years
Mean (SD) 2·8 (2·6) 2·9 (2·9) 3·6 (4·8)
Median (IQR) 1·9 (0·9–4·0) 1·9 (0·7–3·6) 2·1 (1·0–4·5)
Range 0·3–15·7 0·4–12·7 0·4–36·1
Word finding ability, %§
Mean (SD) 42·6 (18·1) 43·7 (19·0) 41·7 (20·6)
Median (IQR) 42·3 (30·0–57·0) 43·0 (30·0–58·2) 37·5(25·0–59·0)
Range 5·0–85·0 4·5–86·0 9·5–82·0
Functional conversation, TOMs¶
Mean (SD) 3·1 (1·0) 2·9 (1·2) 2·7 (1·1)
Median (IQR) 3·0 (2·5–4·0) 3·0 (2·0–4·0) 2·5 (2·0–3·5)
Range 0·5–5·0 0·5–5·0 1·0–4·5
COAST, %**
Mean (SD) 59·8 (13·2) 58·4 (13·6) 59·5 (14·0)
Median (IQR) 61·3 (51·9–68·8) 57·5 (47·5–68·8) 60·0 (48·8–67·5)
Range 26·3–86·3 26·3–87·5 26·3–96·3
Data are n (%), unless otherwise specified. CAT=Comprehensive Aphasia Test. COAST=Communication Outcomes After 
Stroke. CSLT=computerised speech language therapy. TOMs=Therapy Outcomes Measures. *Derived from CAT 
comprehension of sentences test scores out of a total of 32 (within normal limits 27–32; mild 18–26, moderate 9–17, 
severe 0–8). †Derived from CAT Naming objects test out of 48 (mild 31–43; moderate 18–30; severe 5–15). ‡Some 
patients had several strokes, so summaries relate to patients with a particular type of stroke. §Word finding ability of 
personally chosen words based on the Personal Vocabulary Naming Test. ¶TOMs rating score ranges from 0–5, with 
higher scores meaning improved functional communication. **Higher score indicates positive self-perceived 
communication and positive impact on patient’s quality of life.
Table 2: Baseline characteristics of modified intention-to-treat analysis population
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Mean changes in functional communication in con-
versation based on TOMs (the second co-primary outcome) 
were very similar across interventions (table 3; igure 2). 
The mean diference in change between the usual care 
group and the CSLT group was –0·03 (95% CI –0·21 to 0·14; 
p=0·709) and between the CSLT group and attention 
control group was –0·01 (–0·20 to 0·18). There fore, the 
CSLT approach did not appear to improve functional 
communication in conversation.
The mean improvement in COAST in the CSLT group 
compared with the usual care group and the attention 
control group was not suicient to suggest that CSLT 
Usual care CSLT Attention 
control
CSLT vs usual care* CSLT vs attention control† Attention control vs usual 
care†
Adjusted mean 
difference in 
change (95% CI)
p value Adjusted mean 
difference in 
change (95% CI)
p value Adjusted mean 
difference in 
change (95% CI)
p value
Co-primary outcomes
Change in word finding, %‡ 86; 1·1 (11·2) 83; 16·4 (15·3) 71; 2·4 (8·8) 16·2 
(12·7 to 19·6)a
<0·0001 14·4 
(10·8 to 18·1)c
<0·0001 1·8 
(–1·9 to 5·4)
0·338
Change in functional 
communication, TOMs§
84; 0·05 (0·59) 81; 0·04 (0·58) 68; 0·10 (0·61) –0·03 
(–0·21 to 0·14)b
0·709 –0·01 
(–0·20 to 0·18)d
0·915 –0·02 
(–0·21 to 0·17)
0·812
Key secondary outcome
Change in participant’s 
perception of 
communication, social 
participation, and quality of 
life, % (COAST)¶
83; 2·7 (12·6) 82; 3·3 (11·3) 68; –0·3 (12·7) 0·5 
(–3·1 to 4·1)e
0·772 3·8 
(–0·0 to 7·5)f
0·051 –3·2 
(–7·0 to 0·5)
0·089
Data are n; mean (SD), unless otherwise specified. a,b,c,d,e,fReferenced in the appendix (p 16) are the related p values to aid interpretation of the Hochberg procedure for decision-making to claim evidence. 
COAST=Communications Outcomes After Stroke. CSLT=computerised speech language therapy. TOMs=Therapy Outcome Measures. *Usual care as the reference group. †Attention control as the reference group. 
‡Higher scores indicate improved vocabulary of personal importance. §Higher scores indicate improved functional communication ability in conversation. Seven participants had missing TOMs data (video not 
recorded in error, poor sound quality of video, technical issues with the camera, participant declined to do a video, recording failed because of a technical issue, participant unwell and did not want to complete 
the assessment, and participant did not wish to complete assessment). ¶Higher percentage indicates improved participant perception of communication effectiveness and a positive impact on their quality of 
life. Seven participants had invalid COAST records, with more than 10% of applicable items that were unclear or had no response (see statistical analysis plan p 16–17).
Table 3: Co-primary and key secondary outcome results at 6 months in the modified intention-to-treat analysis population
Figure 2: Mean response profile of participants for the co-primary and key secondary outcomes
COAST=Communication Outcomes After Stroke. CSLT=computerised speech language therapy. TOMs=Therapy Outcome Measures. 
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improved the key secondary outcome (participant’s own 
perception of their communication and social partici-
pation or its efect on their life; table 3). The results were 
similar after adjusting for additional covariates: length of 
time post-stroke and location of stroke (see appendix 
p 39). Location of stroke was reported as recorded in 
medical notes, hence a mixture of vascular territories and 
lobes were reported. For other secondary outcomes, on 
average, no improvement was seen in the number of 
treated words used in conversation across groups between 
baseline and 6 months (appendix pp 76–78). Additionally, 
evidence was not suicient to suggest that improved word 
inding of treated words generalised to untreated words 
(appendix p 72). At 6 months, the mean change in word 
inding of untreated words was 3·9 (SD 7·9) in the usual 
care group, 3·3 (7·0) in the CSLT group, and 0·7 (8·5) in 
the attention control group, indicating an adjusted mean 
diference in change of –0·3 (95% CI –2·7 to 2·1) in 
favour of usual care compared with CSLT. Carer-related 
outcomes (ie, change in carer’s perception of patient’s 
com munication and social participation, as assessed 
using the irst 15 items of the CarerCOAST, and change in 
the carer QoL, as assessed using the last ive items of the 
CarerCOAST) are reported in the appendix (pp 81, 100).
Usual care (n=114) CSLT (n=85) Attention control 
(n=79) 
CSLT vs usual care 
(IRR [95%CI])*
CSLT vs attention 
control (IRR 
[95%CI])† 
Attention 
control vs usual 
care (IRR 
[95%CI])*
Experienced at least 
one adverse event
70 (61%) 61 (72%) 50 (63%) ·· ·· ··
Repeated adverse events
All adverse events
Total events per person 
years 
200 per 105·4 185 per 84·7 136 per 74·7 ·· ·· ··
Incidence per person-
year
1·87 (1·47–2·38) 2·18 (1·72–2·77) 1·79 (1·38–2·31) 1·16 (0·83–1·62) 1·22 (0·85–1·77) 0·95 (0·67–1·35)
Felt more tired than usual
Total events per person 
years 
125 per 105·4 114 per 84·7 77 per 74·7 ·· ·· ··
Incidence per person-
year
1·18 (0·82–1·70) 1·32 (0·95–1·84) 1·01 (0·70–1·45) 1·12 (0·69–1·83) 1·32 (0·81–2·14) 0·85 (0·51–1·42)
Had any fits or seizures
Total events per person 
years 
18 per 105·4 47 per 84·7 13 per 74·7 ·· ·· ··
Incidence per person-
year
0·16 (0·06–0·44) 0·57 (0·29–1·12) 0·17 (0·08–0·37) 3·48 (1·05–11·57) 3·41 (1·21–9·62) 1·02 (0·29–3·63)
Had worsening vision or visual difficulties
Total events per person 
years 
47 per 105·4 71 per 84·7 34 per 74·7 ·· ·· ··
Incidence per person-
year
0·42 (0·22–0·80) 0·83 (0·51–1·36) 0·44 (0·25–0·79) 1·95 (0·87–4·37) 1·89 (0·89–4·05) 1·03 (0·43–2·44)
Had increasing number or increasing severity of headaches
Total events per person 
years 
46 per 105·4 52 per 84·7 25 per 74·7 ·· ·· ··
Incidence per person-
year
0·43 (0·23–0·81) 0·58 (0·34– 1·01) 0·31 (0·13–0·78) 1·36 (0·59–3·11) 1·84 (0·64–5·30) 0·74 (0·24–2·21)
Had any accidents (e.g. falls) or injuries
Total events per person 
years 
90 per 105·4 48 per 84·7 51 per 74·7 ·· ·· ··
Incidence per person-
year
0·87 (0·58–1·30) 0·56 (0·35– 0·89) 0·66 (0·42–1·04) 0·64 (0·35–1·19) 0·85 (0·45–1·61) 0·76 (0·42–1·39)
Reported any other negative effects or events
Total events per person 
years 
64 per 105·4 44 per 84·7 29 per 74·7 ·· ·· ··
Incidence per person-
year
0·60 (0·40–0·92) 0·55 (0·35–0·86) 0·38 (0·21–0·68) 0·91 (0·49–1·68) 1·44 (0·69–3·00) 0·63 (0·31–1·28)
Data are n (%), total events per person years, or incidence per person-year (95% CI). Safety analysis using a negative binomial regression model was based on treatment as 
received; therefore, the numbers per group differ from the number randomised to each group (these numbers therefore differ from those in table 3). IRR=incidence rate ratio. 
CSLT=computerised speech language therapy. *Usual care as the reference group. †Attention control as the reference group.
Table 4: Incidences of adverse events in the safety analysis population
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With regard to safety (appendix p 93), negative efects of 
CSLT were low. 23 (27%) of 85 participants in the CSLT 
group reported fatigue or anxiety at some point during the 
6 months of computer use, which translates to one event 
per person per year. The number of participants who 
experienced any adverse events was 70 (61%) in the usual 
care group, 61 (72%) in the CSLT group, and 50 (63%) in 
the attention control group (table 4). These included 
tiredness, its or seizures, visual di culties, and headaches 
(summarised list in table 4 and table 5; appendix p 91). 
The number of participants who experi enced any serious 
adverse events was 18 (16%) in the usual care group, 
nine (11%) in the CSLT group, and 11 (14%) in the attention 
control group (table 5). Examples of serious adverse events 
included admission to hospital due to urinary tract or 
chest infections. Diferences in the incidences of adverse 
events and serious adverse events between groups were 
insuicient to suggest diferences in risk levels. 
Predeined subgroup analyses indicated that the efect 
of CSLT on word inding was broadly consistent regardless 
of time post-stroke and slightly higher for participants 
with mild word inding di culties and for those whose 
verbal comprehension was within normal limits (see 
appendix p 49–51). For functional conversation and per-
ception of communication efectiveness or QoL, the sub-
group and main results were consistent (see appendix 
pp 49, 50, 52, 53).
All participants randomly assigned to the CSLT group 
received the StepByStep aphasia therapy software on 
a computer. Some practice was recorded for all but 
11 participants, with a mean of 28 h (SD 25·6) and a 
median of 21 h (IQR 4·9–49·7) in total between base-
line and 6 months. In comparison, a mean amount of 
3·8 h (SD 7·4) of usual speech and language therapy was 
received by all participants between baseline and 
6 months. 57 (61%) of 94 participants in the CSLT group 
continued to use the computer exercises unsupported 
beyond the 6-month timepoint. Fidelity to CSLT, attention 
control and usual care is described in the appendix 
(p 106). In terms of quality of CSLT delivery, of particular 
note is that volunteers and therapy assistants only spent 
a median of 45 min per participant (IQR  22·0–77·5) over 
the 6 months practising newly learned words in con-
versation. More in depth analysis of idelity of CSLT in 
Big CACTUS is in progress.
Regarding health economic evaluation, the per-patient 
incremental cost of CSLT was £733 (95% credible inter-
val 674 to 798) and the incremental QALY gain was 
0·017 (–0·05 to 0·10), resulting in an ICER of £42 686 per 
QALY gained compared with usual care. For CSLT com-
pared with attention control, the ICER was £40 164 per 
QALY gained. For CSLT compared with usual care, 
participants with mild word inding di culty had an 
ICER of £22 371 per QALY gained and for those with 
moderate word inding di culty, the ICER was £28 819 per 
QALY gained, whereas CSLT was more expensive and 
produced fewer QALYs than usual care for participants 
with severe word inding di culties. 
Usual care 
(n=114)
CSLT 
(n=85)
Attention control 
(n=79)
CSLT vs usual care 
(IRR [95%CI])*
CSLT vs attention 
control 
(IRR [95%CI])†
Attention control 
vs usual care 
(IRR [95%CI])*
Experienced at least 
one serious adverse 
event
18 (16%) 9 (11%) 11 (14%) ·· ·· ··
Repeated serious adverse events
Total events per 
person years 
23 per 105·4 10 per 84·7 12 per 74·7 ·· ·· ··
Incidence per 
person-year
0·23 (0·11–0·34) 0·11 (0·04–0·19) 0·16 (0·06–0·26) 0·51 (0·22–1·19) 0·72 (0·28–1·87) 0·70 (0·31–1·59)
Resulted in hospitalisation
Yes 19 10 11 ·· ·· ··
No 4 0 1 ·· ·· ··
Was life-threatening
Yes 9 3 4 ·· ·· ··
No 14 7 8 ·· ·· ··
Relationship to trial activity
Unlikely 1 2 2 ·· ·· ··
Unrelated 22 8 10 ·· ·· ··
Outcome of serious adverse events
Death‡ 5 2 1 ·· ·· ··
Data are n, n (%), total events per person years, or incidence per person-year (95% CI). Safety analysis using a negative binomial regression model was based on treatment as 
received; therefore, the numbers per group differ from the number randomised to each group (these numbers therefore differ from table 3). CSLT=computerised speech 
language therapy. IRR=incidence rate ratio. *Usual care as the reference group. †Attention control as the reference group. ‡Not treatment-related deaths.
Table 5: Incidences of serious adverse events in the safety analysis population
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Discussion
Big CACTUS shows that CSLT alongside usual care 
enables increased amounts of therapy practice and 
signiicantly improves the ability to retrieve personally 
relevant words chosen for practice. This outcome is likely 
to be due to the CSLT rather than the extra activity of the 
participant or attention provided by the therapy assist ants. 
Improvement in word inding was maintained 6 months 
after the intervention period. However, CSLT did not have 
an efect on conversation, self-perceived improvements in 
everyday communication, social participation, or QoL.
It is notable that 57 (61%) of 94 participants chose to 
continue using the computer program unsupported 
beyond the end of the formal intervention period (if they 
still had access to it), suggesting many participants valued 
the opportunity to continue practising language skills 
independently. Subgroup analysis showed no efect of 
time post-stroke (ranged from 4 months to 36 years in 
this trial) on the ability to improve word inding, showing 
that people can continue to learn new words even a long 
time after the event. This inding supports the indings 
from small studies included in the Cochrane review of 
aphasia therapy,2 that SLT in general beneits patients 
with chronic aphasia.
Big CACTUS supports indications from smaller studies 
that improvements in the ability to ind treated words in 
patients with chronic aphasia do not generalise to 
untreated words.26 Therefore, it is crucial that words of 
personal relevance form the focus of speech and language 
therapy in general to ensure usefulness. However, gen-
eralisation of newly learned words into conversation was 
not seen in the present trial, mirroring the indings in 
motor rehabilitation after stroke, where in the context of 
randomised comparisons with usual care or attention 
control interventions, improvements have been shown in 
motor function, balance, and gait velocity but not 
in functionally relevant activities of daily living.27 The 
indings of the present study therefore suggest that 
identifying ways to support functional use of new words 
is a priority to achieve the goal of improving conversation. 
The CSLT intervention intended that therapy assistants or 
volunteers would practise tasks to promote the use of new 
words in context. However, these tasks were only carried 
out for an average of 45 min in total over 6 months. 
Future studies will need to establish how to ensure 
support for practising words in context and whether 
increased practice in context helps with generalisation.
CSLT can be considered a safe intervention as only a few 
negative efects were reported by participants and the 
groups had no signiicant diferences in incidences of 
adverse events or severe adverse events. Participants in 
the CSLT group spent, on average, 28 h on independent, 
repetitive word inding practice, at a mean cost of £733 per 
participant. In contrast, 28 h of a therapist would cost 
approximately £1400 per patient. Hence, relative to 
providing face-to-face speech and language therapy, CSLT 
is a low-cost option for delivering additional word inding 
therapy to patients with chronic aphasia post-stroke. 
Perhaps unsurprisingly, given that CSLT was not observed 
to afect conversation, the QALY gain associated with 
CSLT compared with usual care was low and the 
intervention is unlikely to be considered cost-efective for 
the whole patient population with aphasia because of the 
size of the incremental cost-efectiveness ratio. However, 
CSLT is more likely to be cost-efective than usual care for 
patients with mild and moderate word-inding di culties. 
The key cost driver of delivering CSLT is time spent setting 
up the software and providing technical support, which in 
our study was done by therapists. These tasks could 
conceivably be done by therapy assistants or volunteers, 
substantially reducing costs. A full discussion of the 
health economic results will be the subject of a further 
publication.
Strengths of the study include recruitment and treat-
ment of participants who are representative of the clinical 
population from a wide range of clinical settings that used 
existing models of IT services to implement CSLT. The 
CSLT intervention also has international applicability and 
is manualised and publicly available, enabling replication. 
Additional study strengths include the addition of a third 
group to enable diferentiation of the efect of speech and 
language therapy components of CSLT from efects of 
additional activity and attention, and observation of idelity 
to the trial interventions. Outcome measures addressed 
impairment, activity, and participation dimensions of 
the WHO International Classiication of Functioning, 
Disability, and Health (ICF).28 Measuring across the ICF 
domains is important as this study suggests that word 
inding improvement (impairment) is not a good surro-
gate measure for functional conversation (activity). The 
trial also included health economic evaluation, and to our 
knowledge, our study is the irst to do this for SLT. The use 
of an accessible version of the EQ-5D-5L permitted 
patients with aphasia to rate their own QoL for QALY 
estimation, rather than relying only on the view of a carer, 
which is not always the same as that of the patient 
themselves.20
A limitation is that only one computer program was 
used of the many commercial programs and apps 
available, and for only one language domain (ie, word 
inding) afected by aphasia. The results of the study also 
need to be considered in context of rapid technological 
advancement. Because the software used was only in 
English, patients who required treatment in a language 
other than English were excluded. Additionally, partici-
pant ethnicity was not recorded. While the intervention 
was given to all eligible participants, further research 
should identify patient characteristics that indicate 
motivation to participate in CSLT and likelihood of a 
good outcome for prudent targeting of the intervention, 
such as aphasia severity, age, and education. Participant 
characteristics inluencing practice will be addressed in a 
further paper. Although data has been presented here on 
the amount of practice carried out, dose response and 
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efect of continued practice are important. Preliminary 
data can be found in the appendix (p 59) and will be 
explored in more detail in further publications.
Despite blocking of the allocation sequence, slightly 
more participants were randomly assigned to CSLT and 
usual care groups compared with the attention control 
group. Sites recruiting small numbers of participants and 
the termination of recruitment after 278 patients might 
have contributed to this chance imbalance, which resulted 
in higher power than expected for the CSLT and usual 
care primary comparison and slightly lower power than 
expected for the CSLT and attention control comparison—
although adequate to address the intended research 
objectives. We used the activity scale of the TOMs to 
measure conversations because it has good reliability and 
is likely to detect clinically meaning ful change, though 
it might not detect small changes.29 Although cost-
efective ness was an important aspect of the study, it was 
not powered to detect a meaningful diference in QALYs. 
Finally, it was not possible to measure the amount of 
activity participants carried out with puzzle books in the 
attention control group with as much accuracy as the 
amount of computer practice carried out and therefore it 
is not known how well the attention control intervention 
controlled for CSLT.
In conclusion, this study has shown that CSLT is a low-
cost intervention enabling access to additional word 
inding therapy for patients with chronic aphasia, leading 
to signiicant improvement in the ability to ind words of 
personal relevance. Further research should focus on 
therapy techniques to promote generalisation of new 
words to functional, everyday communication contexts.
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